BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 35085165)

  • 1. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
    Wegen S; Roth KS; Weindler J; Claus K; Linde P; Trommer M; Akuamoa-Boateng D; van Heek L; Baues C; Schömig-Markiefka B; Schomäcker K; Fischer T; Drzezga A; Kobe C; Köhler C; Marnitz S
    Clin Nucl Med; 2023 Feb; 48(2):150-155. PubMed ID: 36607364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [
    Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison of [
    Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head to head comparison of
    Zhang A; Meng X; Yao Y; Zhou X; Zhang Y; Li N
    Eur Radiol; 2024 Mar; 34(3):1960-1970. PubMed ID: 37668694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome.
    Wang P; Li C; Hou G; Li Z; Jing H; Zhang W; Li F
    Clin Nucl Med; 2023 Sep; 48(9):781-784. PubMed ID: 37543757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast Activation Protein-Targeted PET/CT with
    Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
    J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.
    Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z
    Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of [
    Ji M; Ma G; Liu C; Gu B; Du X; Ou X; Xu X; Song S; Yang Z
    Cancer Imaging; 2024 May; 24(1):56. PubMed ID: 38702821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-Head Comparison of [
    Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
    Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of [
    Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [
    Chen H; Pang Y; Li J; Kang F; Xu W; Meng T; Shang Q; Zhao J; Guan Y; Wu H; Xie F; Wang J; Sun L
    Eur Radiol; 2023 Feb; 33(2):1329-1341. PubMed ID: 35976396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.